rs797046108
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001083961.2(WDR62):c.269+12delA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00782 in 1,610,434 control chromosomes in the GnomAD database, including 140 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0056 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0081 ( 130 hom. )
Consequence
WDR62
NM_001083961.2 intron
NM_001083961.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0610
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 19-36058881-TA-T is Benign according to our data. Variant chr19-36058881-TA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 212602.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}. Variant chr19-36058881-TA-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0056 (854/152380) while in subpopulation SAS AF = 0.0418 (202/4834). AF 95% confidence interval is 0.0371. There are 10 homozygotes in GnomAd4. There are 464 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00561 AC: 854AN: 152262Hom.: 10 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
854
AN:
152262
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00963 AC: 2409AN: 250244 AF XY: 0.0116 show subpopulations
GnomAD2 exomes
AF:
AC:
2409
AN:
250244
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00805 AC: 11742AN: 1458054Hom.: 130 Cov.: 30 AF XY: 0.00920 AC XY: 6671AN XY: 725488 show subpopulations
GnomAD4 exome
AF:
AC:
11742
AN:
1458054
Hom.:
Cov.:
30
AF XY:
AC XY:
6671
AN XY:
725488
Gnomad4 AFR exome
AF:
AC:
39
AN:
33414
Gnomad4 AMR exome
AF:
AC:
146
AN:
44660
Gnomad4 ASJ exome
AF:
AC:
644
AN:
26104
Gnomad4 EAS exome
AF:
AC:
6
AN:
39654
Gnomad4 SAS exome
AF:
AC:
3448
AN:
86136
Gnomad4 FIN exome
AF:
AC:
127
AN:
53394
Gnomad4 NFE exome
AF:
AC:
6647
AN:
1108650
Gnomad4 Remaining exome
AF:
AC:
565
AN:
60284
Heterozygous variant carriers
0
661
1322
1984
2645
3306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00560 AC: 854AN: 152380Hom.: 10 Cov.: 32 AF XY: 0.00623 AC XY: 464AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
854
AN:
152380
Hom.:
Cov.:
32
AF XY:
AC XY:
464
AN XY:
74518
Gnomad4 AFR
AF:
AC:
0.000673206
AN:
0.000673206
Gnomad4 AMR
AF:
AC:
0.00307149
AN:
0.00307149
Gnomad4 ASJ
AF:
AC:
0.0268012
AN:
0.0268012
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.0417873
AN:
0.0417873
Gnomad4 FIN
AF:
AC:
0.00159955
AN:
0.00159955
Gnomad4 NFE
AF:
AC:
0.00646716
AN:
0.00646716
Gnomad4 OTH
AF:
AC:
0.00992439
AN:
0.00992439
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
39
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary Microcephaly 2 With or Without Cortical Malformations Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Nov 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=99/1
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at